None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and Female Trial participants in the age group 35 to 55 years both the ages inclusive. 2. Hair density of greater than or equal to 125 and lesser than or equal to 225 hair follicles per square cm as per TrichoScan measurement. 3. Hair thinning assessment grade between Grade 3 to Grade 6 using photo numerical scale. 4. Trial participants with at least one of the following complaints: dry, damaged hair, brittle and thin hair, hair loss evident while combing or after washing, self-perceived reduced hair density. 5. Trial participants willing to maintain the same hair style, approximate length, and hair color throughout the study. 6. Trial participants willing to undergo shaving of a test area on the scalp and have a mark in the target area
Exclusion criteria
Exclusion criteria: 1. Trial participants who have undergone any kind of hair growth treatment in the last 2 weeks. 2. Trial participants who have undergone hair treatments like smoothing, keratin, cream bath, hair spa, etc. in the last 4 weeks. 3. Trial participants having any active scalp disease which may interfere with the study. 4. Prior use of scalp hair growth treatment e.g., finasteride, minoxidil within 6 months. 5. Trial participants with dandruff or other scalp conditions that require treatment. 6. Trial participants participating in another similar cosmetic or therapeutic trial within the last two weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change from baseline in hair thinning score, hair density score, and hair pull test score as assessed by dermatological evaluation at Day 28, Day 56, and Day 84. 2. Change in anagen to telogen ratio A to T ratio from baseline to Day 84 in participants as measured by TrichoScan. 3. Change in hair growth from baseline across all subsequent time points in participants as measured by TrichoScan. 3. Change in hair density from baseline across all subsequent time points in participants as measured by TrichoScan. 4. Change from baseline in number of terminal hairs at Weeks 4, 8, and 12 as measured by TrichoScan. 5. Change in hair fall from baseline across all subsequent time points as measured by the standardized hair comb test. 6. Change in hair thickness, as measured by Caselite software, compared to baseline and all defined time points.Timepoint: D0, D2, D28, D30, D56, D58, D84, D86 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in perceived hair growth from baseline across all subsequent time points, as evaluated by trial participant self-assessment. 2. Primary irritation and sensitization assessment of the test productTimepoint: D0, D2, D28, D30, D56, D58, D84, D86 | — |
Countries
India
Contacts
MS Clinical Research Pvt Ltd